Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice

Anbarasan Deepti; Campion Gabriel; Campion Paul; Howard Jonathan

首页> 外文期刊>CNS spectrums >Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice

【24h】

Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice

机译：清单征兆可作为多发性硬化症（MS）实践中非脱髓鞘疾病的预测指标的临床效用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives. Not all patients referred for evaluation of multiple sclerosis (MS) meet criteria required for MS or related entities. Identification of markers to exclude demyelinating disease may help detect patients whose presenting symptoms are inconsistent with MS. In this study, we evaluate whether patients who present a self-prepared list of symptoms during an initial visit are less likely to have demyelinating disease and whether this action, which we term the "list sign," may help exclude demyelinating disease.

机译：目标。并非所有转介评估多发性硬化症（MS）的患者都符合MS或相关实体所需的标准。鉴定出排除脱髓鞘疾病的标志物可能有助于发现其症状与MS不一致的患者。在这项研究中，我们评估在初次就诊时呈现自我准备好的症状清单的患者是否较少发生脱髓鞘疾病，我们称之为“清单征兆”的这一行动是否有助于排除脱髓鞘疾病。

著录项

来源
《CNS spectrums》 |2016年第3期|共6页
作者
Anbarasan Deepti; Campion Gabriel; Campion Paul; Howard Jonathan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Demyelinating; diagnosis; list sign; multiple sclerosis; neuropsychiatry; somatic symptom disorder;

机译：脱髓鞘;诊断;清单征;多发性硬化症;神经精神病学;躯体症状障碍;

相似文献

外文文献
中文文献
专利

1. Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice [J] . Anbarasan Deepti, Campion Gabriel, Campion Paul, CNS spectrums . 2016,第3期

机译：清单征兆可作为多发性硬化症（MS）实践中非脱髓鞘疾病的预测指标的临床效用
2. Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study [J] . Weinstock-Guttman Bianca, Medin Jennie, Khan Nasreen, CNS drugs . 2018,第1期

机译：在常规临床实践中，评估延迟多发性硬化患者患者的“无疾病活动证据证明疾病活动”的状态：对美国（MS-MRIUS）研究的多发性硬化临床和磁共振成像结果的回顾性分析
3. The IFNbeta treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, Italy. [J] . Trojano M, Paolicelli D, Zimatore GB, Neurological sciences . 2005,第Suppla4期

机译：临床实践中的IFNbeta治疗多发性硬化症（MS）：意大利Bari MS中心的经验。
4. PROTEIN-BASED BIOMARKER PREDICTS CONVERSION from CLINICALLY ISOLATED SYNDROME to MULTIPLE SCLEROSIS [C] . Eva Borras, Ester Canto, Meena Choi, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：基于蛋白质的生物标志物预测从临床上综合征转化为多发性硬化症
5. MS control, coping, and social support: Relationship to depression in multiple sclerosis [D] . Polen, Dawn M. 2006

机译：MS控制，应对和社会支持：与多发性硬化症中的抑郁症的关系
6. Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study [O] . Bianca Weinstock-Guttman, Jennie Medin, Nasreen Khan, -1

机译：在常规临床实践中评估接受芬戈莫德复发-缓解的多发性硬化症患者的无疾病活动证据状态：美国多发性硬化症临床和磁共振成像结果的回顾性分析（MS-MRIUS）
7. Comparison of prevalence rates of restless legs syndrome, self-assessed risks of obstructive sleep apnea, and daytime sleepiness among patients with multiple sclerosis (MS), clinically isolated syndrome (CIS) and Neuromyelitis Optica Spectrum Disorder (NMOSD) [O] . Vahid Shaygannejad, Dena Sadeghi Bahmani, Parisa Soleimani, 2020

机译：躁动腿综合征的患病率，自评睡眠呼吸暂停的自我评估风险以及多发性硬化症（MS），临床孤立综合征（CIS）和神经髓炎OPTICA谱系（NMOSD）的患者白天嗜睡
8. Summary Report: Workgroup on Human Subjects Protection (IRB) and Health Information Portability and Accountability Act (HIPAA), February 7, 2007: Issues Related to Developing a National Surveillance System and Registries for Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS) [R] . 2007

机译：摘要报告：人类受试者保护工作组（IRB）和健康信息可移植性和责任法案（HIpaa），2007年2月7日：与建立肌萎缩性脊髓侧索硬化症（aLs）和多发性硬化症（ms）的国家监测系统和登记相关的问题

Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice

摘要

著录项

相似文献

相关主题

期刊订阅